Effect of St. John's wort (Hypericum perforatum) on cytochrome P-450 2D6 and 3A4 activity in healthy volunteers

被引:117
作者
Markowitz, JS [1 ]
DeVane, CL
Boulton, DW
Carson, SW
Nahas, Z
Risch, SC
机构
[1] Med Univ S Carolina, Dept Pharmaceut Sci, Charleston, SC 29425 USA
[2] Med Univ S Carolina, Dept Psychiat & Behav Med, Charleston, SC 29425 USA
[3] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA
关键词
St. John's wort; cytochrome P-450; drug interaction; Hypericum perforatum; herb;
D O I
10.1016/S0024-3205(99)00659-1
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The effects of the herb St. John's wort (Hypericum perforatum), a purported antidepressant, on the activity of cytochrome P-450 (CYP) 2D6 and 3A4 was assessed in seven normal volunteers. Probe substrates dextromethorphan (2D6 activity) and alprazolam (3A4 activity) were administered orally with and without the co-administration of St. John's wort. Urinary concentrations of dextromethorphan and dextrorphan were quantified and dextromethorphan metabolic ratios (DMRs) determined. Plasma samples were collected (0-60 hrs) for alprazolam pharmacokinetic analysis sufficient to estimate t(max), C-max, t(1/2), and AUG. Validated HPLC methods were used to quantify all compounds of interest. No statistically significant differences were found in any estimated pharmacokinetic parameter for alprazolam or DMRs. These results suggest that St. John's wort, when taken at recommended doses for depression, is unlikely to inhibit CYP 2D6 or CYP 3A4 activity. (C) 2000 Elsevier Science Inc.
引用
收藏
页码:PL133 / PL139
页数:7
相关论文
共 20 条
[1]   CYP2D6 status of extensive metabolizers after multiple-dose fluoxetine, fluvoxamine, paroxetine, or sertraline [J].
Alfaro, CL ;
Lam, YWF ;
Simpson, J ;
Ereshefsky, L .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1999, 19 (02) :155-163
[2]   Neuropharmacology of St. John's wort (Hypericum) [J].
Bennett, DA ;
Phun, L ;
Polk, JF ;
Voglino, SA ;
Zlotnik, V ;
Raffa, RB .
ANNALS OF PHARMACOTHERAPY, 1998, 32 (11) :1201-1208
[3]   Inhibitory effects of naturally occurring coumarins on the metabolic activation of benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene in cultured mouse keratinocytes [J].
Cai, YN ;
BaerDubowska, W ;
AshwoodSmith, M ;
DiGiovanni, J .
CARCINOGENESIS, 1997, 18 (01) :215-222
[4]   Genetic determinants of drug responsiveness and drug interactions [J].
Caraco, Y .
THERAPEUTIC DRUG MONITORING, 1998, 20 (05) :517-524
[5]   SIMULTANEOUS DETERMINATION OF DEXTROMETHORPHAN AND 3 METABOLITES IN PLASMA AND URINE USING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH APPLICATION TO THEIR DISPOSITION IN MAN [J].
CHEN, ZR ;
SOMOGYI, AA ;
BOCHNER, F .
THERAPEUTIC DRUG MONITORING, 1990, 12 (01) :97-104
[6]   Trends in alternative medicine use in the United States, 1990-1997 - Results of a follow-up national survey [J].
Eisenberg, DM ;
Davis, RB ;
Ettner, SL ;
Appel, S ;
Wilkey, S ;
van Rompay, M ;
Kessler, RC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (18) :1569-1575
[7]   Drug interactions with grapefruit juice - Extent, probable mechanism and clinical relevance [J].
Fuhr, U .
DRUG SAFETY, 1998, 18 (04) :251-272
[8]  
HA HR, 1995, EUR J CLIN PHARMACOL, V48, P367
[9]   Nonlinear mixed effects modeling of single dose and multiple dose data for an immediate release (IR) and a controlled release (CR) dosage form of alprazolam [J].
Hossain, M ;
Wright, E ;
Baweja, R ;
Ludden, T ;
Miller, R .
PHARMACEUTICAL RESEARCH, 1997, 14 (03) :309-315
[10]   Quantification of intraindividual variability and the influence of menstrual cycle phase on CYP2D6 activity as measured by dextromethorphan phenotyping [J].
Kashuba, ADM ;
Nafziger, AN ;
Kearns, GL ;
Leeder, JS ;
Shirey, CS ;
Gotschall, R ;
Gaedigk, A ;
Bertino, JS .
PHARMACOGENETICS, 1998, 8 (05) :403-410